Featured Product
A comprehensive supply chain for semaglutide tablets
GMP oral tablets, in-house API and SNAC, and a transfer-plus-dossier path — take one layer, two, or the full chain.
- GMP tablets
- DMF ready
- CTD · Pakistan
- API up to 3 t/year
Oral tablets
High-quality semaglutide tablets for diabetes and obesity programs in eligible markets.
- Manufactured in fully GMP-qualified facilities
- Cardiovascular use only where the registration path allows
API & SNAC
In-house semaglutide API and intermediates — fermentation plus chemical synthesis — with SNAC sourcing.
- API annual capacity up to 3 tons
- Factory capacity up to 32 tons
Tech transfer & dossier
Pakistan CTD on file, plus a transfer model for rapid local registration and manufacturing.
- Global DMF ready; clinical trials in progress
- ~60% cost vs originator where legally permissible
Our capacity — not originator-brand sales
0 t
Semaglutide API annual production capacity, up to
Industry context
Oral GLP-1 tablets need API, SNAC and a file that can travel. Factory capacity is up to 32 tons. That is why tablets, API and transfer belong in one plan for eligible markets.
For manufacturers and marketers
01Marketing-authorisation holders
02Regional manufacturers
03Distributors
Not a consumer offer, and not originator-branded product.
Why this supply
GMP tablets, a ready file, in-house API and SNAC, and commercial volume already shipped in Southeast Asia.
GMP tablet manufacture
Tablets are made in facilities with complete GMP qualifications. Quality and safety standards are the starting point, not an add-on.
DMF ready, dossier support
Global DMF is ready. Clinical trials are in progress. We can assist dossier submission to the requirements of different health authorities. A CTD dossier is ready for Pakistan.
API, intermediates and SNAC
Semaglutide API and intermediates are developed in-house through fermentation and chemical synthesis, with SNAC sourcing. API capacity up to 3 tons a year; factory capacity up to 32 tons.
Southeast Asia commercial experience
Millions of tablets sold in eight months in Southeast Asia, in markets where that supply was permitted. That is regional commercial experience — not a global launch claim.
How a program starts
Same sequence whether you take tablets, API and SNAC, transfer, or a mix.
- 01
Scope
Strength, markets, volume, and which layers you need — tablets, API and SNAC, transfer, or a combination. We confirm what we can stand behind before work starts.
- 02
Align the file
Specification, DMF / CTD expectations and country-specific dossier needs — written down while gaps are still cheap to close.
- 03
Qualify supply
Tablets and/or API against that spec. Audit findings stay in the same program plan.
- 04
Deliver and hold
First shipment, transfer and local registration support if a receiving site will manufacture, then change control from one owner.
Frequently asked
Ready to scope a supply?
Send the form, the markets and a volume range. We reply with what we can stand behind.